Equities
Basic MaterialsChemicals
  • Price (NOK)193.00
  • Today's Change0.00 / 0.00%
  • Shares traded250.00
  • 1 Year change+4.21%
  • Beta--
Data delayed at least 15 minutes, as of Apr 08 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Borregaard ASA is a Norway-based biorafinery. The Group provides sustainable products and solutions based on renewable raw materials. Its business model is closely linked to the integrated nature of its biorefinery in Norway, which utilises the three key components of wood cellulose fibres, lignin and sugars to produce a diversified portfolio of products. The Company operates through three business segments. BioSolutions develops, produces and sells biopolymers and biovanillin from lignin. BioMaterials develops, produces and sells speciality cellulose mainly for use as a raw material in the production of cellulose ethers, cellulose acetate and other speciality products. Fine Chemicals consists of second-generation bioethanol and intermediates mainly for contrast agents.

  • Revenue in NOK (TTM)7.26bn
  • Net income in NOK839.00m
  • Incorporated2012
  • Employees1.13k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.